Massachusetts AI and Technology Center for Connected Care in Aging and Alzheimer's Disease (MAITC): Pilot (AD ADRD Focus)

马萨诸塞州老龄化和阿尔茨海默病互联护理人工智能和技术中心 (MAITC):试点(AD ADRD 焦点)

基本信息

  • 批准号:
    10899857
  • 负责人:
  • 金额:
    $ 29.91万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-09-30 至 2026-05-31
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY: AD/ADRD Pilot Core The Alzheimer's Disease and Related Dementias (AD/ADRD) Core plays a central role in achieving the goals of the Massachusetts AI and Technology Center for Connected Care in Aging and Alzheimer's Disease (MAITC) by identifying, selecting, advising, and helping to translate innovative pilot projects that use emerging AI-enhanced technologies to address clinically and societally unmet needs in AD/ADRD. The AD/ADRD Pilot Core will draw on the collective clinical, scientific, and technical expertise within MAITC and the valuable input of our Stakeholder Core and Industry Advisory Board to complete the following specific aims: 1) Solicit and select the most meritorious pilot studies that will develop and test novel AI-enhanced technologies that address clinically important questions in AD/ADRD; 2) Provide mentorship, oversight, and resource supports for pilot project investigators; 3) Assist pilot project investigators in refining their methods and translating their technologies for clinical, industry, and research use. The AD/ADRD Pilot Core Leaders (Drs. Jasmeer Chhatwal and Deborah Blacker) will work MAITC’s other core leaders to coordinate and oversee the pilot project process. The AD/ADRD Pilot Core will solicit pilot projects from the training programs, departments, and centers at universities and research institutions across the nation, drawing on an extensive pool of existing investigators who have expertise in areas such as neurology, psychiatry, geriatrics, technology, computer science, and artificial intelligence. Example topic areas for AD/ADRD pilot projects include: (1) Assessing cognitive impairment-related safety concerns in the patient's home environment; (2) Assessing responses to medical and behavioral interventions and promotion of healthy, potentially-protective behaviors in patients with cognitive impairment; and (3) Informing critical but difficult decisions regarding level-of-care transitions and the need for caregiving assistance inside or outside the home. Once selected, each pilot project leader will be assigned two mentors (at least one of whom will have AD/ADRD clinical expertise) who will provide research guidance and facilitate access to needed resources. The AD/ADRD Pilot Core will work with the other MIATC cores and the AITC Coordinating Center to ensure scientific integrity, rigor and reproducibility, and to facilitate IRB approvals, human subject safety, financial management, and regulatory approvals. The AD/ADRD Pilot Core will help pilot investigators identify critical next steps to move their innovations closer to clinical and research use. To this end, we will provide resources to pilot investigators to refine their technologies, make industry contacts, and develop new grant proposals to accelerate the movement of novel technologies towards the ultimate goal of the AD/ADRD Pilot Core—to improve the care and quality of life for patients and caregivers affected by AD/ADRD.
项目总结:AD/ADRD试点核心 阿尔茨海默病和相关痴呆症(AD/ADRD)核心在实现这些目标方面发挥着核心作用 马萨诸塞州人工智能和技术中心的老龄化和阿尔茨海默病连接护理 (MAITC)通过识别,选择,咨询和帮助转化创新的试点项目, 人工智能增强技术,以解决AD/ADRD临床和社会未满足的需求。AD/ADRD试点 核心将利用MAITC内部的集体临床、科学和技术专业知识, 我们的利益相关者核心和行业咨询委员会,以完成以下具体目标:1)征求和 选择最有价值的试点研究,开发和测试新的人工智能增强技术, AD/ADRD中的临床重要问题; 2)为试点提供指导、监督和资源支持 项目调查员; 3)协助试点项目调查员完善其方法,并将其 用于临床、工业和研究的技术。AD/ADRD试点核心领导人(Jasmeer博士 Chhatwal和Deborah Blacker)将与MAITC的其他核心领导人合作,协调和监督试点项目 项目进程。AD/ADRD试点核心将从培训计划、部门和 中心在全国各地的大学和研究机构,利用现有的广泛的池 在神经病学、精神病学、老年医学、技术、计算机等领域具有专业知识的调查人员 科学和人工智能。AD/ADRD试点项目的示例主题领域包括: 患者家庭环境中与认知障碍相关的安全问题;(2)评估对 医疗和行为干预,促进健康,潜在的保护行为, 认知障碍;和(3)告知有关护理水平过渡和 需要家庭内外的帮助。一旦选定,每个试点项目负责人将 指定两名导师(其中至少一人将具有AD/ADRD临床专业知识),他们将提供研究 提供指导并便利获得所需资源。AD/ADRD试点核心将与其他MIATC合作 核心和AITC协调中心,以确保科学的完整性,严谨性和可重复性,并促进 IRB批准、人类受试者安全、财务管理和监管批准。AD/ADRD试点 核心将帮助试点研究人员确定关键的后续步骤,以使他们的创新更接近临床, 研究使用。为此,我们将向试点调查人员提供资源,以改进他们的技术, 行业联系,并制定新的赠款提案,以加速新技术的运动, AD/ADRD试点核心的最终目标是改善患者和护理人员的护理和生活质量 受AD/ADRD影响。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Deepak Ganesan其他文献

Deepak Ganesan的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Deepak Ganesan', 18)}}的其他基金

Massachusetts AI and Technology Center for Connected Care in Aging and Alzheimer's Disease (MAITC): Administrative Core
马萨诸塞州老龄化和阿尔茨海默病互联护理人工智能和技术中心 (MAITC):管理核心
  • 批准号:
    10675677
  • 财政年份:
    2021
  • 资助金额:
    $ 29.91万
  • 项目类别:
Massachusetts AI and Technology Center for Connected Care in Aging and Alzheimer's Disease (MAITC): Pilot (AD ADRD Focus)
马萨诸塞州老龄化和阿尔茨海默病互联护理人工智能和技术中心 (MAITC):试点(AD ADRD 焦点)
  • 批准号:
    10899842
  • 财政年份:
    2021
  • 资助金额:
    $ 29.91万
  • 项目类别:
Massachusetts AI and Technology Center for Connected Care in Aging and Alzheimer's Disease (MAITC): Administrative Core
马萨诸塞州老龄化和阿尔茨海默病互联护理人工智能和技术中心 (MAITC):管理核心
  • 批准号:
    10491809
  • 财政年份:
    2021
  • 资助金额:
    $ 29.91万
  • 项目类别:
Massachusetts AI and Technology Center for Connected Care in Aging and Alzheimer's Disease (MAITC): Clinical Translation and Validation Core
马萨诸塞州老龄化和阿尔茨海默病互联护理人工智能和技术中心 (MAITC):临床转化和验证核心
  • 批准号:
    10491823
  • 财政年份:
    2021
  • 资助金额:
    $ 29.91万
  • 项目类别:
Massachusetts AI and Technology Center for Connected Care in Aging and Alzheimer's Disease (MAITC): Pilot Core (Aging Focus)
马萨诸塞州老龄化和阿尔茨海默病互联护理人工智能和技术中心 (MAITC):试点核心(老龄化焦点)
  • 批准号:
    10491834
  • 财政年份:
    2021
  • 资助金额:
    $ 29.91万
  • 项目类别:
Massachusetts AI and Technology Center for Connected Care in Aging and Alzheimer's Disease (MAITC): Pilot (AD ADRD Focus)
马萨诸塞州老龄化和阿尔茨海默病互联护理人工智能和技术中心 (MAITC):试点(AD ADRD 焦点)
  • 批准号:
    10675688
  • 财政年份:
    2021
  • 资助金额:
    $ 29.91万
  • 项目类别:
Massachusetts AI and Technology Center for Connected Care in Aging and Alzheimer's Disease (MAITC): Pilot (AD ADRD Focus)
马萨诸塞州老龄化和阿尔茨海默病互联护理人工智能和技术中心 (MAITC):试点(AD ADRD 焦点)
  • 批准号:
    10899878
  • 财政年份:
    2021
  • 资助金额:
    $ 29.91万
  • 项目类别:
Massachusetts AI and Technology Center for Connected Care in Aging and Alzheimer's Disease (MAITC): Stakeholder Engagement Core
马萨诸塞州老龄化和阿尔茨海默病互联护理人工智能和技术中心 (MAITC):利益相关者参与核心
  • 批准号:
    10274690
  • 财政年份:
    2021
  • 资助金额:
    $ 29.91万
  • 项目类别:
Massachusetts AI and Technology Center for Connected Care in Aging and Alzheimer's Disease (MAITC): Technology ID & Training Core
马萨诸塞州老龄化和阿尔茨海默病互联护理人工智能和技术中心 (MAITC):技术 ID
  • 批准号:
    10274691
  • 财政年份:
    2021
  • 资助金额:
    $ 29.91万
  • 项目类别:
Massachusetts AI and Technology Center for Connected Care in Aging and Alzheimer's Disease (MAITC): Networking and Mentoring Core
马萨诸塞州老龄化和阿尔茨海默病互联护理人工智能和技术中心 (MAITC):网络和指导核心
  • 批准号:
    10675687
  • 财政年份:
    2021
  • 资助金额:
    $ 29.91万
  • 项目类别:

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 29.91万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 29.91万
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 29.91万
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 29.91万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 29.91万
  • 项目类别:
    Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 29.91万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 29.91万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 29.91万
  • 项目类别:
    Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 29.91万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 29.91万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了